Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 2, 2004, Pages 273-278

  Tooney, Paul A ^a,b   Chahl, Loris A ^b  

^a Neurosci Inst Schizophrenia A   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

BA; Brodmann area; Calbindin; Calcium binding proteins; Calretinin; CB; CR; GABA; Immunohistochemistry; Immunoreactive; Interneurons; IR; Parvalbumin; Prefrontal cortex; PV; Schizophrenia; amino butyric acid

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANTIBODY; CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; PARVALBUMIN;

ADULT; AGE DETERMINATION; AGED; ARTICLE; BRAIN NERVE CELL; CADAVER; CELL DENSITY; CELL SIZE; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INTERNEURON; MALE; PERIKARYON; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RELATIVE DENSITY; SCHIZOPHRENIA; SEX DIFFERENCE; THICKNESS;

EID: 1642441358     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2003.10.004     Document Type: Article

References (22)

1. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E. Jr., Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry. 52:1995;258-266.
2. Beasley C.L., Reynolds G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr. Res. 24:1997;349-355.
3. Beasley C.L., Zhang Z.J., Patten I., Reynolds G.P. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol. Psychiatry. 52:2002;708-715.
4. Benes F.M., Vincent S.L., Marie A., Khan Y. Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience. 75:1996;1021-1031.
5. Cotter D., Landau S., Beasley C., Stevenson R., Chana G., MacMillan L., Everall I. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol. Psychiatry. 51:2002;377-386.
6. Daviss S.R., Lewis D.A. Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res. 59:1995;81-96.
7. Dean B., Hussain T., Hayes W., Scarr E., Kitsoulis S., Hill C., Opeskin K., Copolov D.L. Changes in serotonin(2A) and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex. J. Neurochem. 72:1999;1593-1599.
8. Eyles D.W., McGrath J.J., Reynolds G.P. Neuronal calcium-binding proteins and schizophrenia. Schizophr. Res. 57:2002;27-34.
9. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 98:2001;4746-4751.
10. Hanada S., Mita T., Nishino N., Tanaka C. [3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics. Life Sci. 40:1987;259-266.
11. Lund J.S., Lewis D.A. Local circuit neurons of developing and mature macaque prefrontal cortex: golgi and immunocytochemical characteristics. J. Comp. Neurol. 328:1993;282-312.
12. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 28:2000;53-67.
13. Ohnuma T., Augood S.J., Arai H., McKenna P.J., Emson P.C. Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression. Neuroscience. 93:1999;441-448.
14. Rajkowska G., Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. Cereb. Cortex. 5:1995;307-322.
15. Reynolds G.P., Zhang Z.J., Beasley C.L. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity. Brain Res. Bull. 55:2001;579-584.
16. Sarris M., Garrick T.M., Sheedy D., Harper C.G. Banking for the future: an Australian experience in brain banking. Pathology (Phila.). 34:2002;225-229.
17. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry. 52:1995;805-818.
18. Selemon L.D., Rajkowska G., Goldmanrakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients - application of a three-dimensional, stereological counting method. J. Comp. Neurol. 392:1998;402-412.
19. Tooney P.A., Au G.G., Chahl L.A. Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex. Neurosci. Lett. 283:2000;185-188.
20. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., Lewis D.A. Decreased glutamic acid decarboxylase(67) messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry. 57:2000;237-245.
21. Woo T.U., Miller J.L., Lewis D.A. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am. J. Psychiatry. 154:1997;1013-1015.
22. Woo T.U., Whitehead R.E., Melchitzky D.S., Lewis D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5341-5346.